These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12650885)

  • 1. A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics.
    Groenewegen WA; Bezzina CR; van Tintelen JP; Hoorntje TM; Mannens MM; Wilde AA; Jongsma HJ; Rook MB
    Cardiovasc Res; 2003 Mar; 57(4):1072-8. PubMed ID: 12650885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel.
    Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL
    Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmogenic consequences of Na+ channel mutations in the transmurally heterogeneous mammalian left ventricle: analysis of the I1768V SCN5A mutation.
    Flaim SN; Giles WR; McCulloch AD
    Heart Rhythm; 2007 Jun; 4(6):768-78. PubMed ID: 17556201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
    Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q
    Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo mutation in the SCN5A gene associated with early onset of sudden infant death.
    Wedekind H; Smits JP; Schulze-Bahr E; Arnold R; Veldkamp MW; Bajanowski T; Borggrefe M; Brinkmann B; Warnecke I; Funke H; Bhuiyan ZA; Wilde AA; Breithardt G; Haverkamp W
    Circulation; 2001 Sep; 104(10):1158-64. PubMed ID: 11535573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.
    Deschênes I; Baroudi G; Berthet M; Barde I; Chalvidan T; Denjoy I; Guicheney P; Chahine M
    Cardiovasc Res; 2000 Apr; 46(1):55-65. PubMed ID: 10727653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.
    Rook MB; Bezzina Alshinawi C; Groenewegen WA; van Gelder IC; van Ginneken AC; Jongsma HJ; Mannens MM; Wilde AA
    Cardiovasc Res; 1999 Dec; 44(3):507-17. PubMed ID: 10690282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
    Wang DW; Yazawa K; George AL; Bennett PB
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A de novo missense mutation of human cardiac Na+ channel exhibiting novel molecular mechanisms of long QT syndrome.
    Makita N; Shirai N; Nagashima M; Matsuoka R; Yamada Y; Tohse N; Kitabatake A
    FEBS Lett; 1998 Feb; 423(1):5-9. PubMed ID: 9506831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.
    Wang DW; Crotti L; Shimizu W; Pedrazzini M; Cantu F; De Filippo P; Kishiki K; Miyazaki A; Ikeda T; Schwartz PJ; George AL
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):370-8. PubMed ID: 19808432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel.
    Kambouris NG; Nuss HB; Johns DC; Tomaselli GF; Marban E; Balser JR
    Circulation; 1998 Feb; 97(7):640-4. PubMed ID: 9495298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block.
    Lupoglazoff JM; Cheav T; Baroudi G; Berthet M; Denjoy I; Cauchemez B; Extramiana F; Chahine M; Guicheney P
    Circ Res; 2001 Jul; 89(2):E16-21. PubMed ID: 11463728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome.
    Vatta M; Dumaine R; Varghese G; Richard TA; Shimizu W; Aihara N; Nademanee K; Brugada R; Brugada J; Veerakul G; Li H; Bowles NE; Brugada P; Antzelevitch C; Towbin JA
    Hum Mol Genet; 2002 Feb; 11(3):337-45. PubMed ID: 11823453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism for LQT3 with 2:1 block: a pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation.
    Horne AJ; Eldstrom J; Sanatani S; Fedida D
    Heart Rhythm; 2011 May; 8(5):770-7. PubMed ID: 21193062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.